⌘K

Login Start Free

Home/Filings/4/0001127602-23-018944

4//SEC Filing

Douglas Robert Andrew 4

Accession 0001127602-23-018944

CIK 0000943819other

View on SEC.gov Company Profile

Filed

Jun 19, 8:00 PM ET

Accepted

Jun 20, 12:02 PM ET

Size

5.1 KB

Accession

0001127602-23-018944

Insider Transaction Report

Form 4

Period: 2023-06-15

Douglas Robert Andrew

COO Asia Pacific

Transactions

Sale
ResMed Common Stock
2023-06-15$216.27/sh−1,500$324,405→ 253,526 total(indirect: By Trust)

Holdings

ResMed Common Stock
16,874

Footnotes (1)

[F1]The transaction was conducted under a Rule 10b5-1 plan adopted February 9, 2023.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

RESMED INC

CIK 0000943819

Entity typeother

Related Parties

1

filerCIK 0001352232

Filing Metadata

Form type: 4
Filed: Jun 19, 8:00 PM ET
Accepted: Jun 20, 12:02 PM ET
Size: 5.1 KB

View on SEC.gov